We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$1.28M
Cap. Flow
-$11.4M
Cap. Flow %
-8.5%
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
29
Reduced
140
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.85M
2
ATEC icon
Alphatec Holdings
ATEC
+$2.84M
3
INDV icon
Indivior Pharmaceuticals
INDV
+$2.84M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$2.12M
5
APLS
Apellis Pharmaceuticals
APLS
+$1.76M

Top Sells

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.17M
2
PCRX icon
Pacira BioSciences
PCRX
+$3.36M
3
PFE icon
Pfizer
PFE
+$3.06M
4
UTHR icon
United Therapeutics
UTHR
+$2.79M
5
QURE icon
uniQure
QURE
+$2.06M

Sector Composition

Rank Sector Weight
1 Healthcare 57.92%
2 Real Estate 14.45%
3 Financials 7.05%
4 Industrials 3.2%
5 Technology 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRT icon
151
Vertiv
VRT
$112B
$136K 0.1%
1,371
-38
-3% -$3.15K
URI icon
152
United Rentals
URI
$63.4B
$135K 0.1%
167
-7
-4% -$5.04K
EZA icon
153
iShares MSCI South Africa ETF
EZA
$530M
$134K 0.1%
2,651
-363
-12% -$16.6K
EPU icon
154
iShares MSCI Peru and Global Exposure ETF
EPU
$528M
$132K 0.1%
3,060
+270
+10% +$11K
EPHE icon
155
iShares MSCI Philippines ETF
EPHE
$130M
$132K 0.1%
+4,517
New +$120K
HCA icon
156
HCA Healthcare
HCA
$82.2B
$130K 0.1%
321
-12
-4% -$4.39K
EWM icon
157
iShares MSCI Malaysia ETF
EWM
$308M
$130K 0.1%
4,803
-523
-10% -$12.9K
EIDO icon
158
iShares MSCI Indonesia ETF
EIDO
$486M
$129K 0.1%
+5,718
New +$121K
GREK
159
Global X MSCI Greece ETF
GREK
$279M
$128K 0.1%
2,972
– –
APP icon
160
Applovin
APP
$143B
$128K 0.1%
979
-27
-3% -$2.46K
INDA icon
161
iShares MSCI India ETF
INDA
$6.78B
$126K 0.09%
2,157
-151
-7% -$8.6K
PGNY icon
162
Progyny
PGNY
$2.49B
$126K 0.09%
+7,500
New +$180K
EWT icon
163
iShares MSCI Taiwan ETF
EWT
$9.8B
$125K 0.09%
2,314
-117
-5% -$6.22K
BNY
164
Bank of New York Mellon
BNY
$108B
$123K 0.09%
1,718
-55
-3% -$3.62K
EPOL icon
165
iShares MSCI Poland ETF
EPOL
$661M
$123K 0.09%
5,067
+208
+4% +$5.02K
LUNR icon
166
Intuitive Machines
LUNR
$2.22B
$121K 0.09%
+15,000
New +$74.6K
EWP icon
167
iShares MSCI Spain ETF
EWP
$1.95B
$115K 0.09%
3,265
+34
+1% +$1.12K
EWG icon
168
iShares MSCI Germany ETF
EWG
$1.5B
$115K 0.09%
3,391
-1
-0% -$32
EWD icon
169
iShares MSCI Sweden ETF
EWD
$513M
$114K 0.08%
2,624
+30
+1% +$1.22K
TRGP icon
170
Targa Resources
TRGP
$60.6B
$114K 0.08%
768
-26
-3% -$3.66K
EWQ icon
171
iShares MSCI France ETF
EWQ
$322M
$112K 0.08%
2,775
+167
+6% +$6.5K
EWI icon
172
iShares MSCI Italy ETF
EWI
$908M
$111K 0.08%
2,848
+47
+2% +$1.76K
EWN icon
173
iShares MSCI Netherlands ETF
EWN
$562M
$111K 0.08%
2,179
+55
+3% +$2.73K
EWU icon
174
iShares MSCI United Kingdom ETF
EWU
$3.97B
$110K 0.08%
2,948
-46
-2% -$1.67K
UHS icon
175
Universal Health Services
UHS
$9.12B
$110K 0.08%
481
-18
-4% -$3.88K
5 6
7
8 9

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, AlphaCentric Advisors held 245 positions worth $135M, down 0.95% from $136M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

AlphaCentric Advisors withdrew a net $11.4M in Q3 2024, closing 15 positions and reducing 140 holdings. Its most notable exit was BioCryst Pharmaceuticals, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 60% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Merck worth $2.73M.

  • AlphaCentric Advisors's largest Q3 2024 buy was Merck: 24,000 shares worth $2.73M.
  • AlphaCentric Advisors added most to Neurocrine Biosciences in Q3 2024, an estimated $2.12M increase.
  • AlphaCentric Advisors's biggest Q3 2024 reduction was Pfizer, cutting an estimated $3.06M.
  • AlphaCentric Advisors fully exited BioCryst Pharmaceuticals in Q3 2024, selling an estimated $4.17M.
  • AlphaCentric Advisors's ten largest holdings make up 21% of its $135M portfolio in Q3 2024.
  • AlphaCentric Advisors opened 28 new positions and closed 15 in Q3 2024.
  • AlphaCentric Advisors's portfolio value fell 0.95% quarter-over-quarter to $135M.

Based on AlphaCentric Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.